LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Canertinib | 1.11 | uM | LJP6 | 72 | hr | 1657 | 4617 | 5505 | 0.8386 | 0.7691 |
| BT-20 | Celastrol | 1.11 | uM | LJP6 | 72 | hr | 1657 | 2358 | 5505 | 0.4284 | 0.1822 |
| BT-20 | CGP60474 | 1.11 | uM | LJP5 | 72 | hr | 1657 | 1516 | 5505 | 0.2754 | -0.0368 |
| BT-20 | CGP60474 | 1.11 | uM | LJP6 | 72 | hr | 1657 | 1035 | 5505 | 0.1881 | -0.1617 |
| BT-20 | CHIR-99021 | 1.11 | uM | LJP6 | 72 | hr | 1657 | 5500 | 5505 | 0.9990 | 0.9986 |
| BT-20 | CP724714 | 1.11 | uM | LJP5 | 72 | hr | 1657 | 4568 | 5505 | 0.8298 | 0.7565 |
| BT-20 | CP466722 | 1.11 | uM | LJP5 | 72 | hr | 1657 | 5755 | 5505 | 1.0453 | 1.0649 |
| BT-20 | Crizotinib | 1.11 | uM | LJP5 | 72 | hr | 1657 | 4527 | 5505 | 0.8224 | 0.7458 |
| BT-20 | Momelotinib | 1.11 | uM | LJP5 | 72 | hr | 1657 | 4190 | 5505 | 0.7612 | 0.6583 |
| BT-20 | Dasatinib | 1.11 | uM | LJP5 | 72 | hr | 1657 | 1580 | 5505 | 0.2871 | -0.0200 |
| BT-20 | Dasatinib | 1.11 | uM | LJP6 | 72 | hr | 1657 | 1453 | 5505 | 0.2639 | -0.0532 |
| BT-20 | Dovitinib | 1.11 | uM | LJP5 | 72 | hr | 1657 | 2850 | 5505 | 0.5177 | 0.3098 |
| BT-20 | Enzastaurin | 1.11 | uM | LJP5 | 72 | hr | 1657 | 6392 | 5505 | 1.1610 | 1.2304 |
| BT-20 | Erlotinib | 1.11 | uM | LJP5 | 72 | hr | 1657 | 4901 | 5505 | 0.8903 | 0.8430 |
| BT-20 | Foretinib | 1.11 | uM | LJP5 | 72 | hr | 1657 | 1764 | 5505 | 0.3205 | 0.0278 |
| BT-20 | R406 | 1.11 | uM | LJP6 | 72 | hr | 1657 | 5457 | 5505 | 0.9912 | 0.9874 |
| BT-20 | Pictilisib | 1.11 | uM | LJP6 | 72 | hr | 1657 | 2331 | 5505 | 0.4235 | 0.1751 |
| BT-20 | Gefitinib | 1.11 | uM | LJP6 | 72 | hr | 1657 | 5052 | 5505 | 0.9176 | 0.8821 |
| BT-20 | Geldanamycin | 1.11 | uM | LJP5 | 72 | hr | 1657 | 1916 | 5505 | 0.3480 | 0.0671 |
| BT-20 | Geldanamycin | 1.11 | uM | LJP6 | 72 | hr | 1657 | 1894 | 5505 | 0.3441 | 0.0615 |
| BT-20 | GSK1059615 | 1.11 | uM | LJP5 | 72 | hr | 1657 | 1221 | 5505 | 0.2219 | -0.1133 |
| BT-20 | GSK1059615 | 1.11 | uM | LJP6 | 72 | hr | 1657 | 1366 | 5505 | 0.2482 | -0.0757 |
| BT-20 | GSK1904529A | 1.11 | uM | LJP6 | 72 | hr | 1657 | 5222 | 5505 | 0.9485 | 0.9263 |
| BT-20 | Omipalisib | 1.11 | uM | LJP6 | 72 | hr | 1657 | 1187 | 5505 | 0.2157 | -0.1223 |
| BT-20 | GSK 690693 | 1.11 | uM | LJP5 | 72 | hr | 1657 | 3817 | 5505 | 0.6933 | 0.5612 |